Free Trial

Design Therapeutics (DSGN) Short Interest Ratio & Short Volume

Design Therapeutics logo
$5.20
-0.04 (-0.76%)
(As of 11/1/2024 ET)

Design Therapeutics Short Interest Data

Design Therapeutics (DSGN) has a short interest of 2.62 million shares, representing 8.16% of the float (the number of shares available for trading by the public). This marks a 1.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.7, indicating that it would take 9.7 days of the average trading volume of 243,685 shares to cover all short positions.

Current Short Interest
2,620,000 shares
Previous Short Interest
2,580,000 shares
Change Vs. Previous Month
+1.55%
Dollar Volume Sold Short
$14.12 million
Short Interest Ratio
9.7 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
56,620,000 shares
Float Size
32,100,000 shares
Short Percent of Float
8.16%
Today's Trading Volume
69,394 shares
Average Trading Volume
243,685 shares
Today's Volume Vs. Average
28%
Short Selling Design Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Design Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DSGN Short Interest Over Time

DSGN Days to Cover Over Time

DSGN Percentage of Float Shorted Over Time

Design Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20242,620,000 shares $14.12 million +1.6%8.2%9.7 $5.39
9/30/20242,580,000 shares $13.88 million -0.4%8.0%9.7 $5.38
9/15/20242,590,000 shares $14.35 million +18.3%8.1%9.7 $5.54
8/31/20242,190,000 shares $10.40 million -25.5%6.8%8.7 $4.75
8/15/20242,940,000 shares $12.61 million -17.4%9.2%15.7 $4.29
7/31/20243,560,000 shares $18.16 million +16.7%10.7%17.3 $5.10
7/15/20243,050,000 shares $13.66 million +3.4%9.2%14.5 $4.48
6/30/20242,950,000 shares $9.88 million +2.8%8.9%12.4 $3.35
6/15/20242,870,000 shares $10.65 million +2.5%8.7%10.8 $3.71
5/31/20242,800,000 shares $11.34 million -1.8%8.4%9.6 $4.05
5/15/20242,850,000 shares $12.85 million -4.7%8.6%9.6 $4.51
4/30/20242,990,000 shares $10.52 million +25.1%9.1%9.8 $3.52
4/15/20242,390,000 shares $9.06 million +7.2%7.2%9.3 $3.79
3/31/20242,230,000 shares $8.99 million +4.2%6.8%9 $4.03
3/15/20242,140,000 shares $5.52 million -24.9%6.5%8.2 $2.58
2/29/20242,850,000 shares $7.92 million +1.1%8.8%11.3 $2.78
2/15/20242,820,000 shares $7.16 million +16.1%8.7%9 $2.54
1/31/20242,430,000 shares $5.76 million -3.2%7.5%6.2 $2.37
1/15/20242,510,000 shares $6.12 million -11.0%7.7%5.8 $2.44
12/31/20232,820,000 shares $7.47 million +9.7%8.7%6.6 $2.65
12/15/20232,570,000 shares $6.58 million -19.2%7.9%6.1 $2.56
11/30/20233,180,000 shares $7.63 million +1.6%9.8%7.4 $2.40
11/15/20233,130,000 shares $7.26 million +0.3%9.6%5.2 $2.32
10/31/20233,120,000 shares $6.36 million +6.1%9.6%3.3 $2.04
10/15/20232,940,000 shares $6.29 million +0.7%9.0%3.2 $2.14
9/30/20232,920,000 shares $6.89 million +2.1%9.0%3.2 $2.36
9/15/20232,860,000 shares $7.35 million +24.4%8.8%3.2 $2.57
8/31/20232,300,000 shares $5.70 million -42.2%7.1%2.6 $2.48
8/15/20233,980,000 shares $8.62 million -41.0%12.2%6.2 $2.17
7/31/20236,750,000 shares $54.95 million -2.3%20.8%30.3 $8.14
7/15/20236,910,000 shares $47.96 million -0.4%21.3%26.7 $6.94
6/30/20236,940,000 shares $43.72 million -7.2%21.3%26.4 $6.30
6/15/20237,480,000 shares $40.99 million +5.2%23.0%27.1 $5.48
5/31/20237,110,000 shares $40.03 million -5.0%21.9%19.9 $5.63
5/15/20237,480,000 shares $50.94 million +35.5%23.0%19.1 $6.81
4/30/20235,520,000 shares $35.60 million +2.6%17.0%13.1 $6.45
4/15/20235,380,000 shares $27.92 million -3.2%16.5%12 $5.19
3/31/20235,560,000 shares $32.08 million -23.9%17.1%12.4 $5.77
3/15/20237,310,000 shares $51.24 million -3.1%22.5%15.4 $7.01
2/28/20237,540,000 shares $53.31 million +5.2%23.2%13.1 $7.07
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

2/15/20237,170,000 shares $49.26 million -1.2%22.1%12.7 $6.87
1/31/20237,260,000 shares $56.99 million +8.2%25.1%13.2 $7.85
1/15/20236,710,000 shares $60.39 million +3.1%20.7%12.6 $9.00
12/30/20226,510,000 shares $66.79 million +28.9%21.2%12.9 $10.26
12/15/20225,050,000 shares $40.96 million +11.5%20.2%9.8 $8.11
11/30/20224,530,000 shares $63.42 million -10.7%14.3%11.2 $14.00
11/15/20225,070,000 shares $72.30 million -1.7%16.0%14.5 $14.26
10/31/20225,160,000 shares $80.60 million +7.3%16.6%15.6 $15.62
10/15/20224,810,000 shares $75.90 million -11.4%15.5%16.1 $15.78
9/30/20225,430,000 shares $90.79 million +23.7%17.5%19.6 $16.72
9/15/20224,390,000 shares $99.78 million +10.6%14.1%16.6 $22.73
8/31/20223,970,000 shares $80.43 million -14.4%12.8%19.8 $20.26
8/15/20224,640,000 shares $118.64 million +14.6%14.9%24.6 $25.57
7/31/20224,050,000 shares $79.46 million -4.0%13.0%22.4 $19.62
7/15/20224,220,000 shares $77.82 million -1.4%13.6%20.7 $18.44
6/30/20224,280,000 shares $59.92 million +2.9%13.8%21.3 $14.00
6/15/20224,160,000 shares $56.95 million -7.6%13.4%21.5 $13.69
5/31/20224,500,000 shares $56.16 million +10.0%14.5%27.8 $12.48
5/15/20224,090,000 shares $44.70 million +0.7%13.2%25.5 $10.93
4/30/20224,060,000 shares $48.48 million +37.2%13.1%26.2 $11.94
4/15/20222,960,000 shares $45.11 million +2.4%9.6%18.6 $15.24
3/31/20222,890,000 shares $46.67 million -3.0%9.4%19 $16.15
3/15/20222,980,000 shares $51.91 million +20.7%10.5%19.2 $17.42
2/28/20222,470,000 shares $33.52 million +14.4%8.7%12.4 $13.57
2/15/20222,160,000 shares $31.92 million -4.9%9.5%11 $14.78
1/31/20222,270,000 shares $28.69 million +4.1%8.0%11.5 $12.64
1/15/20222,180,000 shares $34.55 million No ChangeN/A0 $15.85
12/31/20212,180,000 shares $46.67 million -19.3%7.7%12.4 $21.41
12/15/20212,700,000 shares $54.97 million +11.6%9.6%15.4 $20.36
11/30/20212,420,000 shares $40.51 million +25.4%8.6%21.2 $16.74
11/15/20211,930,000 shares $38.41 million +38.9%6.8%18.8 $19.90
10/29/20211,390,000 shares $21.80 million +0.7%4.9%15.7 $15.68
10/15/20211,380,000 shares $19.67 million -14.3%4.9%16.4 $14.25
9/30/20211,610,000 shares $23.65 million -3.6%5.7%20.3 $14.69
9/15/20211,670,000 shares $26.12 million +9.9%5.9%15.3 $15.64
8/31/20211,520,000 shares $23.89 million -26.6%5.4%11 $15.72
8/13/20212,070,000 shares $34.18 million No Change7.3%14.7 $16.51

DSGN Short Interest - Frequently Asked Questions

What is Design Therapeutics' current short interest?

Short interest is the volume of Design Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 2,620,000 shares of DSGN short. 8.16% of Design Therapeutics' shares are currently sold short. Learn More on Design Therapeutics' current short interest.

What is a good short interest ratio for Design Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DSGN shares currently have a short interest ratio of 10.0. Learn More on Design Therapeutics's short interest ratio.

What is a good short interest percentage for Design Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.16% of Design Therapeutics' floating shares are currently sold short.

Is Design Therapeutics' short interest increasing or decreasing?

Design Therapeutics saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 2,620,000 shares, an increase of 1.6% from the previous total of 2,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Design Therapeutics' float size?

Design Therapeutics currently has issued a total of 56,620,000 shares. Some of Design Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Design Therapeutics currently has a public float of 32,100,000 shares.

How does Design Therapeutics' short interest compare to its competitors?

8.16% of Design Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Design Therapeutics: Editas Medicine, Inc. (22.22%), Voyager Therapeutics, Inc. (6.33%), Sangamo Therapeutics, Inc. (8.75%), Atai Life Sciences (8.19%), Syros Pharmaceuticals, Inc. (4.82%), Precision BioSciences, Inc. (5.77%), Burning Rock Biotech Limited (1.42%), Castle Biosciences, Inc. (6.34%), Calliditas Therapeutics AB (publ) (0.01%), Autolus Therapeutics plc (3.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Design Therapeutics stock?

Short selling DSGN is an investing strategy that aims to generate trading profit from Design Therapeutics as its price is falling. DSGN shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Design Therapeutics?

A short squeeze for Design Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DSGN, which in turn drives the price of the stock up even further.

How often is Design Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DSGN, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:DSGN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners